Humacyte, Inc. - Common Stock · Transaction May 3, 2024 · Filed Aug 5, 2026 · $1,001 to $15,000
XNAS · HUMA
+2.55% · +$0.0143 · Vol Not reported
Pre-market · updated 06:25:39 ET
Humacyte, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
$0.5749
Veridion Score
BETAHIGH CONF · 6/6 factorsMon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET · HUMA
MethodologyHUMA
Humacyte, Inc. Common Stock
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
SELL BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
38/ 100
Veridion Score
SELL BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is HUMA moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Humacyte, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Listed since
2021
Employees
184
Country
US
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$0.5606
Last session
Day high
$0.5606
Last session
Day low
$0.5606
Last session
Previous close
$0.5606
52W high
$2.48
-76.82% from high
52W low
$0.5500
1% of range
Market cap
$168M
EPS
$-0.6000
Beta
2.35
Shares out
277.8M
Avg volume
7.4M
VWAP
$0.5606
Last session
Price history computed in-house
1W
-19.03%
1M
-13.51%
3M
-37.32%
1Y
-68.06%
YTD
-40.15%
SMA 50 $0.7814 · below
SMA 200 $0.9924 · below
52W position 1%
HUMA overview
Related filings and maps
Public disclosures
Congress activity in HUMA
Official filing ↗
Humacyte, Inc. - Common Stock · Transaction May 3, 2024 · Filed Aug 5, 2026 · $15,001 to $50,000
Humacyte, Inc. - Common Stock · Transaction Apr 30, 2024 · Filed May 15, 2024 · $50,001 to $100,000
Humacyte Inc · Transaction Mar 21, 2024 · Filed Aug 5, 2026 · $1,001 to $15,000
Humacyte, Inc. - Common Stock · Transaction Mar 21, 2024 · Filed Aug 5, 2026 · $15,001 to $50,000
Federal contracts
HUMA contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HUMA in this window.
Lobbying spend
HUMA lobbying filings, year to date.
Registered lobbying filings matched to Humacyte, Inc. Common Stock.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HUMA in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for HUMA.
Options
Sovereign unlock shows live options positioning for HUMA.